St. Jude Medical Pays $3.65 Million to End Investigation
Published: Jun 01, 2012
Little Canada-based St. Jude (NYSE: STJ) failed to apply pricing credits for pacemakers and defibrillators it sold to the departments of Defense and Veterans Affairs, the federal government alleged.
The allegations stemmed from a whistleblower suit. The whistleblowers will receive $730,000 from the settlement, the Journal reported.